DNA polymerase beta expression in head & neck cancer modulates the poly(ADP-ribose)-mediated replication checkpoint. [PDF]
Khan MM +8 more
europepmc +1 more source
The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments - parallels with other neurodegenerative disorders. [PDF]
Ordaz DA, Gupta K, Bota DA.
europepmc +1 more source
Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer. [PDF]
Rimel BJ +19 more
europepmc +1 more source
Synthesis of Novel Substituted <i>N</i>‑Heterocycles and Their Use of Selective Poly(ADP-ribose) Polymerase 1 (PARP1) Inhibitors. [PDF]
Zhou X, Liang SH.
europepmc +1 more source
Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy: Multicenter, Observational Study. [PDF]
Piątek S +9 more
europepmc +1 more source
Poly ADP-ribose signaling is dysregulated in Huntington disease. [PDF]
Maiuri T +20 more
europepmc +1 more source
Versatile Modular Antibodies for Sensitive and Specific Detection of Poly-ADP-Ribose
Dauben H, Matić I.
europepmc +1 more source
Poly(ADP-ribose) binding sites on collagen I fibrils for nucleating intrafibrillar bone mineral. [PDF]
Zecca MA, Greer HF, Müller KH, Duer MJ.
europepmc +1 more source
Regulation of stress granule maturation and dynamics by poly(ADP-ribose) interaction with PARP13. [PDF]
Cheng SJ +8 more
europepmc +1 more source
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death [PDF]
al., et +4 more
core +1 more source

